📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. (2021)

First Author: Freitas CS

Attributed to: VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00436-020-06971-2

PubMed Identifier: 33191446

Publication URI: http://europepmc.org/abstract/MED/33191446

Type: Journal Article/Review

Volume: 120

Parent Publication: Parasitology research

Issue: 1

ISSN: 0932-0113